REVEALED: 15 | Rare Historical Photos

Felix Munkonge obituary

Other lives: Specialist in cell biology who helped with the development of a Covid-19 vaccine and treatments for cystic fibrosis

The Guardian - UK · Dec 27, 2023

AstraZeneca buys Chinese cancer therapy firm Gracell for $1.2bn

Gracell Biotechnologies acquisition marks China’s growing importance to the Anglo-Swedish drugmaker

The Guardian - UK · Dec 26, 2023

AstraZeneca buys US vaccine company in $1.1bn deal

Britain’s biggest drugmaker acquires Seattle-based firm Icosavax, expanding vaccine and immune therapy business

The Guardian - UK · Dec 12, 2023

The corporate world is falling short in the fight against climate change

Only 20% of the top 1,000 companies have targets to reduce their emissions, a sign not enough leaders are taking climate change seriously.

Fortune · Nov 15, 2023

AstraZeneca sued over jab: could it be down to a misunderstanding of how risk is calculated?

A multi-million-pound landmark “vaccine damage” case is set to take place in London’s High Court. The test case is being pursued by Jamie Scott who suffered a severe brain injury in April 2021 after receiving the Oxford-AstraZeneca vaccine.

The Conversation · Nov 14, 2023

AstraZeneca makes big push into weight-loss market with obesity pill deal

UK drugmaker signs agreement with China’s Eccogene to work on an obesity and type 2 diabetes pill

The Guardian - UK · Nov 9, 2023

FTSE 100 Live: London blue-chips climb, AstraZeneca results, Flutter and S4 Capital shares tumble

Shares in FTSE 100 heavyweight Diageo have tumbled after it cut guidance due to lower-than-expected demand in Latin America and the Caribbean.

Evening Standard · Nov 9, 2023

Why some people got blood clots after the AstraZeneca vaccine – new clues

AstraZeneca in partnership with the University of Oxford developed one of the first vaccines against COVID. The vaccine, which used an adenovirus to smuggle instructions into human cells to make antibodies against the novel coronavirus, saved countless lives. But a problem soon emerged. A tiny proportion – about one in…

The Conversation · Oct 30, 2023

We could see thunderstorm asthma in south-eastern Australia this season – here's how to prepare

Victorians have been warned to prepare for the possibility of thunderstorm asthma again this season.

The Conversation · Oct 30, 2023

A new RSV shot for infants is in short supply

A new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should prioritize giving the drug to babies at the highest risk of severe disease

The Independent UK · Oct 24, 2023